View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
July 11, 1990


By CBR Staff Writer

Microsoft Corp chairman Bill Gates has so much experience with bugs that he is diversifying into engineering a few of the things: he is the largest shareholder, with 10%, in a new Seattle biotechnology company, Icos Corp, which plans to develop biological and pharmaceutical products for rheumatoid arthritis, multiple sclerosis, asthma and other inflammatory diseases; Gates also holds rights to buy another 10% of Icos at market prices during the next 10 years; it has raised $33m in venture funding altogether.

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how New Statesman Media Group may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.